While limited by few samples exhibiting low ADAM12 staining, comparison of disease-free survival subdivided into stages I, II, and II indicated that strong ADAM12 expression in especially stage III rectal tumors is a good discriminator for patient survival post-surgery and RT (Supplementary Fig. 1A). Here, ADAM12 is linked to rectal neoplasm.